The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts

Prostaglandin E2 Inhibits p53 in Human Breast Adipose Stromal Cells: A Novel Mechanism for the Regulation of Aromatase in Obesity and Breast Cancer

(2015) X. Wang et al.   CANCER RESEARCH

Regioselective hydroxylation of steroid hormones by human cytochromes P450

(2015) Toshiro Niwa et al.   DRUG METABOLISM REVIEWS

Unknown

(2015)   International Journal of Immunogenetics

From immunosuppression to tolerance

(2015) David H. Adams et al.   JOURNAL OF HEPATOLOGY

The effects of drugs with immunosuppressive or immunomodulatory activities on xenobiotics-metabolizing enzymes expression in primary human hepatocytes

(2015) Radim Vrzal et al.   TOXICOLOGY IN VITRO

Effects ofCYP3A5genotypes,ABCB1 C3435TandG2677T/Apolymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients

(2015) LiQin Zhu et al.   XENOBIOTICA

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

(2014) Christine E. Staatz et al.   ARCHIVES OF TOXICOLOGY

Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism

(2014) Barbara Döring et al.   DRUG METABOLISM REVIEWS

Current and emerging strategies for the prevention of graft-versus-host disease

(2014) Sung Won Choi et al.   Nature Reviews Clinical Oncology

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

(2014) L Rojas et al.   PHARMACOGENOMICS JOURNAL

The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation

(2014) Gerold Thölking et al.   PLoS One

Effects of Combinational CYP3A5 6986A>G Polymorphism in Graft Liver and Native Intestine on the Pharmacokinetics of Tacrolimus in Liver Transplant Patients

(2014) Jefferson A. Buendia et al.   THERAPEUTIC DRUG MONITORING

Use of Graft-Derived Cell-Free DNA as an Organ Integrity Biomarker to Reexamine Effective Tacrolimus Trough Concentrations After Liver Transplantation

(2014) Michael Oellerich et al.   THERAPEUTIC DRUG MONITORING

Influence of Cytochrome P450 (CYP) 3A4*1G Polymorphism on the Pharmacokinetics of Tacrolimus, Probability of Acute Cellular Rejection, and mRNA Expression Level of CYP3A5 Rather than CYP3A4 in Living-Donor Liver Transplant Patients

(2013) Miwa Uesugi et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Obesity and breast cancer: role of inflammation and aromatase

(2013) Evan R Simpson et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

PharmGKB summary

(2013) Vishal Lamba et al.   Pharmacogenetics and Genomics

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review

(2013) J.C. Stingl et al.   PHARMACOLOGY & THERAPEUTICS

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

(2012) Robert Dupuis et al.   CLINICA CHIMICA ACTA

Combinational Effect of Intestinal and Hepatic CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Recipients of Living Donor Liver Transplantation

(2012) Eunhee Ji et al.   TRANSPLANTATION

CYP17 inhibitors for prostate cancer therapy

(2010) Tadas S. Vasaitis et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Gene Expression of P-glycoprotein and Cytochrome P450 3A4 in Peripheral Blood Mononuclear Cells and Correlation With Expression in Liver

(2010) C.-Y. Lee et al.   TRANSPLANTATION PROCEEDINGS

Therapeutic Monitoring of Mycophenolate in Transplantation: Is It Justified?

(2009) Katherine Barraclough et al.   CURRENT DRUG METABOLISM

Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report

(2009) Barbara Dołęgowska et al.   TRANSPLANT INTERNATIONAL